Name: Simvastatin Delivery. Challenges & Opportunities
SKU: 64756283
Price: 3174.23 MXN
Availability: InStock
Author: Alberto A C C Pais;Joao J S Sousa;Carla Vitorino
ISBN: 9781634821483

portada Simvastatin Delivery. Challenges & Opportunities

Simvastatin Delivery. Challenges & Opportunities

Formato

Libro Físico

Editorial

Nova Science Publishers

Autor

Alberto A C C Pais;Joao J S Sousa;Carla Vitorino

Año

2015

N° páginas

119

Encuadernación

Tapa Dura

Dimensiones

23.4x15.7x1.5 cm

ISBN13

9781634821483

Simvastatin Delivery. Challenges & Opportunities

Alberto A C C Pais;Joao J S Sousa;Carla Vitorino (Autor) · Nova Science Publishers · Tapa Dura

Libro Nuevo Importado

Envío: 12 a 17 días háb.

$ 5,290.39$ 3,174.23

-40%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 2 unidades

$ 3,174.23

¡Envío Gratis! Llega entre el 23 Sep y el 01 Oct a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Simvastatin Delivery. Challenges & Opportunities"

This book presents an overview of recent developments for an "old drug", simvastatin. It belongs to the class of statins, the most commonly prescribed drugs for the treatment of dyslipidemia or related diseases, being considered of superior effectiveness for that purpose. Now, millions of patients benefit from the use of simvastatin in preventing coronary heart disease (25 million in 2005 in the United States alone). Additionally, simvastatin has been recently identified as a multifaceted drug, addressing different physiological and pathological conditions, thus extending beyond the conventional cholesterol-dependent mechanisms. It has triggered the development of new strategies in order to promote the respective delivery through novel routes of administration. In this book, a comprehensive selection of topics is presented, encompassing aspects that firstly include chemical synthesis, pharmacology and pharmacoeconomics. In the second part, several delivery systems for new therapeutic areas are explored. These comprise of nanoemulsions administered through the parenteral route, nanostructured lipid carriers for transdermal delivery and supramolecular systems for local applications. Cancer therapy and bone regeneration are some of the therapeutic targets addressed along with the classical treatment of hypercholesterolemia, now in drug combination therapies. This book benefits from the participation of recognised experts from different areas. These include researchers from pharmaceutical technology, pharmacology, synthetic chemistry, and members of regulatory boards.